ALZAMEND NEURO
Live / Registered — Registered (as of 12 Mar 2024)
What this means for you
Registered since 12 Mar 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97977458
- Registration number
- 7327470
- Mark type
- Stylized text
- Filed
- 29 Jun 2022
- Published for opposition
- 16 May 2023
- Registered
- 12 Mar 2024
- Attorney of record
- DAVID R. CONKLIN
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical, biologic and immunological research and development; pharmaceutical, biologic and immunological product development; pharmaceutical, biologic and immunological drug and vaccine development services
Owner
- Alzamend Neuro, Inc., Atlanta, GA, US
- Alzamend Neuro, Inc., Atlanta, GA, US
- Alzamend Neuro, Inc., Atlanta, GA, US
Prosecution history
- 12 Mar 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 12 Mar 2024 — REGISTERED-PRINCIPAL REGISTER
- 06 Feb 2024 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 25 Jan 2024 — NOTICE OF ALLOWANCE CANCELLED
- 06 Feb 2024 — DIVISIONAL PROCESSING COMPLETE
- 25 Jan 2024 — DIVISIONAL REQUEST RECEIVED
- 05 Feb 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 Jan 2024 — TEAS REQUEST TO DIVIDE RECEIVED
- 13 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Jan 2024 — SOU EXTENSION 1 GRANTED
- 11 Jan 2024 — SOU EXTENSION 1 FILED
- 11 Jan 2024 — SOU TEAS EXTENSION RECEIVED
- 11 Jul 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 May 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 May 2023 — PUBLISHED FOR OPPOSITION